Universe Pharmaceuticals (UPC) Acquisitions (2022 - 2024)

Universe Pharmaceuticals has disclosed Acquisitions across 3 years of filings, most recently posting $3.5 million for Q1 2024.

• Acquisitions for Q1 2024 came in at $3.5 million, down 4.88% year-over-year; the trailing twelve-month figure through Mar 2024 was $3.5 million (down 4.88% YoY), and the FY2023 annual result was $3.4 million, down 2.5% from the prior year.
• Acquisitions came in at $3.5 million for Q1 2024 at Universe Pharmaceuticals, up from $3.4 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $3.6 million in Q1 2023 to a low of $3.4 million in Q3 2023.
• The 3-year median for Acquisitions is $3.5 million (2022), against an average of $3.5 million.
• Across the five-year window, Acquisitions dropped 2.5% in 2023 and slipped 4.88% in 2024, its largest moves.
• Universe Pharmaceuticals' Acquisitions stood at $3.5 million in 2022, then slipped by 2.5% to $3.4 million in 2023, then climbed by 1.05% to $3.5 million in 2024.
• The last three Acquisitions figures came in at $3.5 million (Q1 2024), $3.4 million (Q3 2023), and $3.6 million (Q1 2023), per Business Quant data.